Cost-effectiveness analysis of anastrozole versus tamoxifen in adjuvant therapy for early-stage breast cancer--a health-economic analysis based on the 100-month analysis of the ATAC trial and the German health system

Michael P Lux; Achim Wöckel; Agnes Benedict; Stefan Buchholz; Noémi Kreif; Nadia Harbeck; Rolf Kreienberg; Manfred Kaufmann; Matthias W Beckmann; Walter Jonat

Cost-effectiveness analysis of anastrozole versus tamoxifen in adjuvant therapy for early-stage breast cancer--a health-economic analysis based on the 100-month analysis of the ATAC trial and the German health system

Michael P Lux, Achim Wöckel, Agnes Benedict, Stefan Buchholz, Noémi Kreif, Nadia Harbeck, Rolf Kreienberg, Manfred Kaufmann, Matthias W Beckmann, Walter Jonat

Centre for Health Economics

Research output: Contribution to journal › Article › peer-review

Original language	Undefined/Unknown
Pages (from-to)	155-166
Number of pages	12
Journal	Oncology Research and Treatment
Volume	33
Issue number	4
Publication status	Published - 2010

Cite this

Lux, M. P., Wöckel, A., Benedict, A., Buchholz, S., Kreif, N., Harbeck, N., Kreienberg, R., Kaufmann, M., Beckmann, M. W., & Jonat, W. (2010). Cost-effectiveness analysis of anastrozole versus tamoxifen in adjuvant therapy for early-stage breast cancer--a health-economic analysis based on the 100-month analysis of the ATAC trial and the German health system. Oncology Research and Treatment, 33(4), 155-166.

@article{2b3c5e6802bb4fd28a76e1b7cc758809,

title = "Cost-effectiveness analysis of anastrozole versus tamoxifen in adjuvant therapy for early-stage breast cancer--a health-economic analysis based on the 100-month analysis of the ATAC trial and the German health system",

author = "Lux, {Michael P} and Achim W{\"o}ckel and Agnes Benedict and Stefan Buchholz and No{\'e}mi Kreif and Nadia Harbeck and Rolf Kreienberg and Manfred Kaufmann and Beckmann, {Matthias W} and Walter Jonat",

year = "2010",

language = "Undefined/Unknown",

volume = "33",

pages = "155--166",

journal = "Oncology Research and Treatment",

publisher = "Karger Publishers",

number = "4",

}

Lux, MP, Wöckel, A, Benedict, A, Buchholz, S, Kreif, N, Harbeck, N, Kreienberg, R, Kaufmann, M, Beckmann, MW & Jonat, W 2010, 'Cost-effectiveness analysis of anastrozole versus tamoxifen in adjuvant therapy for early-stage breast cancer--a health-economic analysis based on the 100-month analysis of the ATAC trial and the German health system', Oncology Research and Treatment, vol. 33, no. 4, pp. 155-166.

Cost-effectiveness analysis of anastrozole versus tamoxifen in adjuvant therapy for early-stage breast cancer--a health-economic analysis based on the 100-month analysis of the ATAC trial and the German health system. / Lux, Michael P; Wöckel, Achim; Benedict, Agnes et al.
In: Oncology Research and Treatment, Vol. 33, No. 4, 2010, p. 155-166.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Cost-effectiveness analysis of anastrozole versus tamoxifen in adjuvant therapy for early-stage breast cancer--a health-economic analysis based on the 100-month analysis of the ATAC trial and the German health system

AU - Lux, Michael P

AU - Wöckel, Achim

AU - Benedict, Agnes

AU - Buchholz, Stefan

AU - Kreif, Noémi

AU - Harbeck, Nadia

AU - Kreienberg, Rolf

AU - Kaufmann, Manfred

AU - Beckmann, Matthias W

AU - Jonat, Walter

PY - 2010

Y1 - 2010

M3 - Article

VL - 33

SP - 155

EP - 166

JO - Oncology Research and Treatment

JF - Oncology Research and Treatment

IS - 4

ER -